Literature DB >> 3758140

Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication.

W Schaumann, B Kaufmann, P Neubert, A Smolarz.   

Abstract

17 patients with severe digoxin intoxication were successfully treated with 320 to 480 mg Fab fragments of digoxin-specific IgG from sheep. The infusion period ranged between 0.5 and 7 h. Serum and urine concentrations of digoxin bound to Fab fragments, and in 11 cases unbound Fab fragments in serum, were determined during and after the infusion. The renal clearance of bound digoxin and therefore of the antibody was 13.6 ml/min. The median extrarenal clearance of the Fab fragments was 10.9 ml/min. The half-life of the serum concentrations starting at 12 h was 14.3 h, and the value was increased to 25.4 h when regression began at 24 h; the corresponding apparent distribution volumes were 25.9 and 541. These figures exceed the volume of the extracellular space and suggest intracellular penetration of the Fab fragments. The dosage of the antibody should be sufficiently high to bind digoxin in the most severe cases of poisoning. The maximum serum concentrations of bound antibody were 30 mg/l after 3 h and 20 mg/l after 5 h. A loading dose of 160 mg followed by an infusion of 0.5 mg/min was sufficient to absorb digoxin re-diffusing into the serum during the first 8 h. In some cases free digoxin reappeared in the serum 8-12 h after beginning the treatment. This might be prevented by infusing a further ampoule at a rate of 0.1 mg/min or less.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758140     DOI: 10.1007/bf00542410

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.

Authors:  T W Smith; E Haber; L Yeatman; V P Butler
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

3.  Massive digoxin poisoning treated with Fab fragments of digoxin-specific antibodies.

Authors:  D J Murphy; W F Bremner; E Haber; V P Butler; T W Smith; W E Gaum
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

4.  Treatment of a case of lanatoside C intoxication with digoxin-specific F(ab')2 antibody fragments.

Authors:  T Hess; P Stucki; S Barandun; G Scholtysik; W Riesen
Journal:  Am Heart J       Date:  1979-12       Impact factor: 4.749

5.  Fab fragments of digoxin-specific antibodies used to reverse ventricular fibrillation induced by digoxin ingestion in a child.

Authors:  A R Zucker; S J Lacina; D S DasGupta; H A Fozzard; D Mehlman; V P Butler; E Haber; T W Smith
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

6.  [Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)].

Authors:  A Smolarz; E Roesch; H Lenz; P Neubert; U Abshagen
Journal:  Z Kardiol       Date:  1984-02

7.  [Treatment of life-threatening digoxin poisoning with heterologous digoxin-specific antibody fragments].

Authors:  G Wahl; J Bücking; H Hübner; M Schwartau
Journal:  Dtsch Med Wochenschr       Date:  1983-09-23       Impact factor: 0.628

8.  Preparation of monoclonal antibodies against DNA-cytosine-5-methyltransferase from human placenta.

Authors:  S Kaul; G P Pfeifer; D Drahovsky
Journal:  Eur J Cell Biol       Date:  1984-07       Impact factor: 4.492

9.  Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments.

Authors:  T L Wenger; V P Butler; E Haber; T W Smith
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

10.  Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.

Authors:  T W Smith; V P Butler; E Haber; H Fozzard; F I Marcus; W F Bremner; I C Schulman; A Phillips
Journal:  N Engl J Med       Date:  1982-11-25       Impact factor: 91.245

View more
  20 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  EJCP and clinical toxicology: the first 40 years.

Authors:  D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  2007-11-16       Impact factor: 2.953

3.  Functional antagonism by a monoclonal antibody to digoxin in a test system of cultured rat heart myocytes.

Authors:  G Wallukat; H U Simon; W D Müller; I Wolf
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 4.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

5.  Kinetics of digoxin and anti-digoxin antibody fragments during treatment of digoxin toxicity.

Authors:  A J Sinclair; D S Hewick; P C Johnston; I H Stevenson; M Lemon
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

6.  Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.

Authors:  David Czock; Frieder Keller; Hanna M Seidling
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

7.  [Digitalis poisoning: treatment with antibodies].

Authors:  W Forth
Journal:  Klin Wochenschr       Date:  1986-01-15

8.  Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.

Authors:  N J Cano; A E Sabouraud; K Benmoussa; F Roquet; I Navarro-Teulon; J C Mani; J M Scherrmann
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

9.  Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.

Authors:  C V Thanh-Barthet; M Urtizberea; A E Sabouraud; N J Cano; J M Scherrmann
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

10.  The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.

Authors:  P C Johnston; I H Stevenson; D S Hewick
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.